ISMMS, Boehringer Ingelheim to test nintedanib for treating pulmonary fibrosis post-COVID-19…
The primary endpoint of the study is percent change in forced vital capacity, a measurement of lung function, compared to baseline…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.